Anna Damato

Anna Damato, PhD, is a seasoned research analyst at Kennedy Capital Management since January 2021, specializing in biotechnology equity research. Damato completed a Doctor of Philosophy in Neuroscience at Washington University School of Medicine in St. Louis, where research focused on the circadian biology of brain tumors and circadian medicine. Prior experience includes leading The BALSA Group as President, managing project negotiations and client relationships, and acting as a director of human resources. Damato has also served in various research capacities at prestigious institutions, including internships at the Pasteur Foundation and Rutgers, and held a teaching assistant role in France, achieving advanced French proficiency. Educational background includes a Bachelor’s Degree in Neuroscience from The College of Wooster.